US-based Celerion and the Korean Drug Development Fund (KDDF) have signed a collaboration agreement aimed at strengthening early phase clinical research in South Korea.

A memorandum of understanding (MoU) has been signed by Celerion and KDDF to provide drug development expertise and support for the emerging drug discovery and development industry in South Korea.

The agreement will support a sharing of knowledge between KDDF and Celerion, providing the framework for collaborations of mutual benefit to both organisations.

"Together with Celerion, KDDF will be able to provide professional consulting services to the Korean research communities to advance research activities and promote innovation."

The collaboration will focus on developing innovative and efficient ways to bring Korean drug discoveries to the global market. It enhances both organisations’ ability to effectively apply principles of translational medicine to the development of innovative new drugs.

KDDF funded companies will have access to Celerion’s extensive experience and expertise in early clinical research and bioanalysis, as well as the global footprint of external partner sites.

Celerion will support all programmes with KDDF from the recently announced business expansion within the Biomedical Research Institute at Seoul National University Hospital, South Korea.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

KDDF CEO Dongho Lee said that the collaboration between KDDF and Celerion is for building effective partnerships between government, industry and academia.

"Together with Celerion, KDDF will be able to provide professional consulting services to the Korean research communities to advance the research activities and promote important innovation," Lee said.